(AGENPARL) - Roma, 7 Giugno 2023 - (AGENPARL) – BRUXELLES mer 07 giugno 2023 In January 2022, the European Commission proposed a stronger mandate for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) to ensure that the Agency can react effectively to new challenges, provide better support to Member States, and contribute to developments at the international level. During the June 2023 plenary session, Parliament is set to vote on the provisional agreement resulting from interinstitutional negotiations.
Fonte : © Unione europea, 2023 – PE
Fonte/Source: https://www.europarl.europa.eu/thinktank/it/document/EPRS_ATA(2023)747928